George Kaiser Family Foundation Homology Medicines, Inc. Transaction History

George Kaiser Family Foundation

  • $654 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$0.53 - $1.14 $141,612 - $304,601
267,194 Added 679.54%
306,514 $186,000
Q3 2023

Nov 13, 2023
BUY
$0.84 - $1.43 $33,028 - $56,227
39,320 New
39,320 $46,000

Others Institutions Holding FIXX

# of Institutions
3
Shares Held
66.2K
Call Options Held
0
Put Options Held
0
View Full List

About Homology Medicines, Inc.

FIXX Quotes by TradingView
  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track George Kaiser Family Foundation Portfolio

Follow George Kaiser Family Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of George Kaiser Family Foundation, based on Form 13F filings with the SEC.

News

Stay updated on George Kaiser Family Foundation with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email